Sanofi Statistics

Total Valuation

Sanofi has a market cap or net worth of GBP 107.91 billion. The enterprise value is 116.77 billion.

Market Cap	107.91B
Enterprise Value	116.77B

Important Dates

The last earnings date was Thursday, January 30, 2025.

Earnings Date	Jan 30, 2025
Ex-Dividend Date	May 13, 2024

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	-0.02%
Shares Change (QoQ)	+0.05%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	1.13B

Valuation Ratios

The trailing PE ratio is 23.47.

PE Ratio	23.47
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	6.57
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 11.73, with an EV/FCF ratio of 23.99.

EV / Earnings	25.40
EV / Sales	3.19
EV / EBITDA	11.73
EV / EBIT	15.82
EV / FCF	23.99

Financial Position

The company has a current ratio of 1.46, with a Debt / Equity ratio of 0.23.

Current Ratio	1.46
Quick Ratio	0.62
Debt / Equity	0.23
Debt / EBITDA	1.50
Debt / FCF	3.04
Interest Coverage	13.84

Financial Efficiency

Return on equity (ROE) is 7.30% and return on invested capital (ROIC) is 5.88%.

Return on Equity (ROE)	7.30%
Return on Assets (ROA)	4.28%
Return on Invested Capital (ROIC)	5.88%
Return on Capital Employed (ROCE)	8.56%
Revenue Per Employee	441,893
Profits Per Employee	55,479
Employee Count	82,878
Asset Turnover	0.34
Inventory Turnover	1.38

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +19.35% in the last 52 weeks. The beta is 0.46, so Sanofi's price volatility has been lower than the market average.

Beta (5Y)	0.46
52-Week Price Change	+19.35%
50-Day Moving Average	97.96
200-Day Moving Average	96.18
Relative Strength Index (RSI)	61.10
Average Volume (20 Days)	476,102

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Sanofi had revenue of GBP 36.62 billion and earned 4.60 billion in profits. Earnings per share was 3.67.

Revenue	36.62B
Gross Profit	25.71B
Operating Income	7.33B
Pretax Income	5.59B
Net Income	4.60B
EBITDA	9.65B
EBIT	7.33B
Earnings Per Share (EPS)	3.67

Full Income Statement

Balance Sheet

The company has 6.25 billion in cash and 14.81 billion in debt, giving a net cash position of -8.56 billion.

Cash & Cash Equivalents	6.25B
Total Debt	14.81B
Net Cash	-8.56B
Net Cash Per Share	n/a
Equity (Book Value)	64.39B
Book Value Per Share	51.13
Working Capital	11.10B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 7.51 billion and capital expenditures -2.64 billion, giving a free cash flow of 4.87 billion.

Operating Cash Flow	7.51B
Capital Expenditures	-2.64B
Free Cash Flow	4.87B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 70.21%, with operating and profit margins of 20.03% and 12.55%.

Gross Margin	70.21%
Operating Margin	20.03%
Pretax Margin	15.26%
Profit Margin	12.55%
EBITDA Margin	26.34%
EBIT Margin	20.03%
FCF Margin	13.29%

Dividends & Yields

This stock pays an annual dividend of 3.23, which amounts to a dividend yield of 3.11%.

Dividend Per Share	3.23
Dividend Yield	3.11%
Dividend Growth (YoY)	5.08%
Years of Dividend Growth	1
Payout Ratio	84.60%
Buyback Yield	0.02%
Shareholder Yield	3.13%
Earnings Yield	4.26%
FCF Yield	4.51%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a